title: Outcome after carotid endarterectomy for asymptomatic carotid stenosis.
abstract: OBJECTIVE
  To compare the long-term outcome in patients with asymptomatic carotid stenosis (ACS) among those treated with carotid endarterectomy (CE) or medical therapy.
  
  
  BACKGROUND
  Until randomized trials are completed, treatment of ACS will depend on identification of subgroups likely to benefit from CE.
  
  
  METHODS
  A retrospective cohort study was done on 215 patients with ACS: 107 underwent CE, and 108 were treated medically (MED). A neurologist reviewed medical records and performed a telephone interview to detect outcome (stroke and death). Mean follow-up was 3.8 years; only 4% were lost to follow-up.
  
  
  RESULTS
  Among CE patients, there was a 4.7% risk of postoperative ipsilateral stroke within 30 days. Four of five postoperative strokes occurred among patients with prior contralateral symptoms. There was no significant difference between CE and MED in the cumulative life-table 5-year risk of ipsilateral stroke, any stroke, or survival free of any stroke. Among diabetics, however, there were no ipsilateral strokes at 5 years after CE compared to 20% in MED (p = 0.03). Excluding postoperative complications, the 5-year risk of ipsilateral stroke was reduced among CE patients who "ever smoked" (CE 1%, MED 8%, p = 0.03) and the 5-year risk of any stroke was reduced among CE patients who had no prior myocardial infarction (CE 6%, MED 16%, p = 0.02). Among those with prior contralateral carotid territory symptoms, the 5-year risk of any stroke was worse in the MED patients (CE 5% MED 32%, p = 0.004). Among CE patients, a Cox proportional hazards model determined that the independent predictors of worse long-term outcome were: a history of myocardial infarction; admission systolic blood pressure greater than 160 mm Hg; and age greater than 65.
  
  
  CONCLUSIONS
  The approach to patients with ACS will await completion of large, randomized clinical trials, now in progress. Even if these studies are negative, there may remain specific subgroups of patients who show clear benefit from carotid endarterectomy.
authors.affiliation: Department of Neurology, Columbia Presbyterian Medical Center, New York, NY.
authors.forename: R B
authors.initials: RB
authors.lastname: Libman
authors.forename: R L
authors.initials: RL
authors.lastname: Sacco
authors.forename: T
authors.initials: T
authors.lastname: Shi
authors.forename: J W
authors.initials: JW
authors.lastname: Correll
authors.forename: J P
authors.initials: JP
authors.lastname: Mohr
mesh_terms: D000328:Adult; D000368:Aged; D016893:Carotid Stenosis / Q000401:mortality / Q000503:physiopathology / Q000601:surgery*; D002561:Cerebrovascular Disorders / Q000401:mortality; D015331:Cohort Studies; D016894:Endarterectomy, Carotid; D005260:Female; D006801:Humans; D008297:Male; D016016:Proportional Hazards Models; D012189:Retrospective Studies; D012307:Risk Factors; D016019:Survival Analysis; D016896:Treatment Outcome